BCR and chronic myelogenous leukemia, BCR-ABL1 positive: A well-described example is BCR-ABL1, a fusion gene that confers tumor growth factor independence, inhibits apoptosis, and is the defining molecular aberration in chronic myelogenous leukemia (CML) (95% of cases) [3].